Diffuse Cutaneous Aphthosis After Combined Targeted Cancer Therapies and Responsive to Pentoxifylline

被引:0
|
作者
Larocca, Cecilia A. [1 ,2 ]
Fay, Christopher J. [1 ,2 ]
Hirner, Jesse P. [3 ]
Meyerhardt, Jeffrey A. [4 ]
Cleary, James M. [4 ]
Dewan, Anna K. [5 ]
LeBoeuf, Nicole R. [1 ,2 ]
机构
[1] Dana Farber Canc Inst, Ctr Cutaneous Oncol, Dept Dermatol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, 450 Brookline Ave, Boston, MA 02215 USA
[3] Univ Missouri Hlth Care, Dept Dermatol, Columbia, MO USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5] Vanderbilt Univ, Med Ctr, Dept Dermatol, Nashville, TN USA
关键词
D O I
10.1001/jamadermatol.2023.2649
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This case series describes 3 patients who developed cutaneous aphthosis while taking an epidermal growth factor receptor inhibitor in combination with an MEK inhibitor.
引用
收藏
页码:1136 / 1139
页数:4
相关论文
共 50 条
  • [1] Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer Part II. Targeted therapies
    Marie Reyes-Habito, Claire
    Roh, Ellen K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (02) : 217.e1 - 217.e11
  • [2] Docetaxel combined with targeted therapies in metastatic breast cancer
    Cortes, Javier
    Roche, Henri
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 387 - 396
  • [3] Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancer
    Montagna, Emilia
    Colleoni, Marco
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [4] Attacking c-Myc: Targeted and Combined Therapies for Cancer
    Huang, Huilin
    Weng, Hengyou
    Zhou, Hui
    Qu, Lianghu
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (42) : 6543 - 6554
  • [5] Management of side effects of targeted therapies in renal cancer: cutaneous side effects
    Robert, Caroline
    Gimel, Pierre
    BULLETIN DU CANCER, 2011, 98 : S35 - S46
  • [6] Survey of cutaneous adverse reactions to targeted cancer therapies: value of dermatological advice
    Damiani, Giovanni
    Manganoni, Ausilia
    Cazzaniga, Simone
    Naldi, Luigi
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (05): : 658 - 661
  • [7] Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings
    Haynes, Dylan
    Morgan, Eric E.
    Chu, Emily Y.
    HUMAN PATHOLOGY, 2023, 140 : 129 - 143
  • [8] Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives
    Zhang, Yan
    Li, Yafei
    Fu, Qiuxia
    Han, Zhiqiang
    Wang, Daijie
    Shinge, Shafiu A. Umar
    Muluh, Tobias Achu
    Lu, Xiaohong
    CURRENT CANCER DRUG TARGETS, 2023, 23 (04) : 251 - 264
  • [9] Combined targeted therapies in non-small cell lung cancer: a winner strategy?
    Cascone, Tina
    Gridelli, Cesare
    Ciardiello, Fortunato
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (02) : 98 - 102
  • [10] Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment
    Si, Yingnan
    Guan, JiaShiung
    Xu, Yuanxin
    Chen, Kai
    Kim, Seulhee
    Zhou, Lufang
    Jaskula-Sztul, Renata
    Liu, X. Margaret
    PHARMACEUTICS, 2020, 12 (11) : 1 - 13